Skip to content

Clinical trials

Phase 1 Blastic Plasmacytoid Dendritic Cell Neoplasm trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm Phase: Phase 1 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20172
20182
20191
20203
20222
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting5
Completed4
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center2
Dana-Farber Cancer Institute2
Fred Hutchinson Cancer Center2
Cellectis S.A.1
Chongqing Precision Biotech Co., Ltd1
Institute of Hematology and Blood Transfusion, Czech Republic1
MacroGenics1
Mayo Clinic1
National Cancer Institute (NCI)1
Orca Biosystems, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blastic Plasmacytoid Dendritic Cell Neoplasm17
Leukemia, Myeloid, Acute11
Myelodysplastic Syndromes7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia, Biphenotypic, Acute6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Hematologic Neoplasms4
Leukemia, Myelomonocytic, Chronic4
Blast Crisis3
Burkitt Lymphoma3

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.